Related Experiment Video
Updated: Sep 15, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Predischarge Betamethasone in Infants Diagnosed With Bronchopulmonary Dysplasia
Tal-El Ernest1, Doreen Ozalvo1, Orna Staretz-Chacham1
1Neonatal Department and Faculty of Health Sciences, Soroka University Medical Center, Ben-Gurion University of the Negev, Beersheba, Israel.
Insights
A short betamethasone therapy course for infants with Bronchopulmonary Dysplasia (BPD) may help wean them from oxygen, potentially shortening hospital stays. Further research is needed to confirm these findings for BPD treatment.
Area of Science:
- Neonatology
- Pediatric Pulmonology
- Pharmacology
Background:
- Bronchopulmonary Dysplasia (BPD) is a chronic lung disease in premature infants.
- Oxygen therapy and hospital readmissions are common complications of BPD.
Purpose of the Study:
- To evaluate the impact of a short betamethasone course on oxygen therapy needs post-discharge.
- To assess the effect on post-menstrual age (PMA) at discharge and hospital readmission rates for infants with BPD.
Main Methods:
- Retrospective cohort study of 187 infants diagnosed with BPD between 2012 and 2020.
- Data extracted from computerized medical records, including demographic and clinical parameters.
- Analysis compared infants treated with and without betamethasone.
Main Results:
- 151 infants received betamethasone; 110 were discharged without supplemental oxygen.
- No significant differences in home oxygen use or PMA at discharge between groups.
- Infants weaned from oxygen on betamethasone were discharged earlier (39.6 weeks).
- Respiratory support at 36 weeks PMA and multiple betamethasone courses predicted oxygen need at discharge.
Conclusions:
- Betamethasone therapy may facilitate oxygen weaning in BPD infants.
- Corticosteroid use might contribute to shorter hospital stays for BPD patients.
Background:
The aim of this study was to assess the influence of a short betamethasone therapy course for infants diagnosed with BPD on the need of oxygen therapy after discharge home, on post-menstrual age (PMA) discharge, and on hospital readmission rates.
Methods:
This was a retrospective cohort study that included infants born and diagnosed with BPD in the Soroka University Medical Center neonatal department between 2012 and 2020. Demographic and clinical parameters were extracted from computerized medical files.
Results:
Overall, 187 infants were included in the study; 151 (81%) were treated with betamethasone, of them 110 (73%) were discharged home without supplemental oxygen. Nonsignificant differences were found between infants treated with or without betamethasone regarding home oxygen supplementation at discharge (27% treated vs. 17% without, p = 0.192) and PMA at discharge (40.2 weeks treated vs. 41.2 weeks not treated, p = 0.114). Of the infants receiving betamethasone, those weaned from oxygen were discharged home at an earlier PMA (39.6 ± 5.0 vs. 42.0 ± 3.7 week, p < 0.001) and there was no difference between readmission rates due to respiratory problems of infants discharged home without oxygen supplementation to those discharged with oxygen (37/108 [34%] vs. 14/36 [39%], p = 0.615). In multivariable analysis, respiratory support at 36 weeks PMA (odds ratio: 4.4 [CI: 1.5-13.2], p < 0.009) and receiving two or more courses of betamethasone (odds ratio: 3.6 [CI: 1.2-10.5], p = 0.009) were significant predictors for need of oxygen supplementation at discharge.
Conclusions:
Use of corticosteroids for infants diagnosed with BPD may shorten hospital stay by promoting weaning from oxygen therapy.
More Related Videos
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Breathing
Pulmonary Cycle: Exhalation
Inhaled Medications
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...

